K. Nogami et al., INVOLVEMENT OF PLATELET-ACTIVATING-FACTOR (PAF) IN GLUTAMATE NEUROTOXICITY IN RAT NEURONAL CULTURES, Brain research, 754(1-2), 1997, pp. 72-78
To clarify the role of platelet-activating factor (PAF) in glutamate n
eurotoxicity, in vitro experiments using primary neuronal cultures wer
e performed. The anti-PAF immunoglobulin-G (aPAF-IgC) and the three PA
F receptor antagonists (BN52021, CV6209, and E5880) were tested for th
eir neuroprotective activity in primary neuronal cultures isolated fro
m embryonic rat cerebral cortex. The cultured neurons were exposed to
glutamate (1 mM) for 60 min. Twenty-four hours after this exposure, aP
AF-IgG demonstrated evidence of protective effects against neuronal da
mage in a dose-dependent manner. Protective effects also; were observe
d in cultures treated with the three PAF antagonists (P < 0.05 at 1 mu
g/ml aPAF-IgG, P < 0.01 at 100 mu M BN52O21, P < 0.05 at 10 nM CV6209
and P < 0.01 at 10 nM E5880). The Fura-2 assay was used to estimate w
hether low dosages of exogenous PAF affect cultured neurons. The cultu
red neurons were loaded with Fura-2/AM. After preincubation for 120 mi
n, the Fura-2-loaded neurons were exposed to various concentrations of
PAF for 60 min. By measuring the fluorescent intensity of the medium
as representing the amount of Fura-2 released from damaged neurons, we
detected an increased release of Fura-2, even at low doses of PAF (P
< 0.01 at 10 nM PAF). We further studied PAF production by neurons in
response to glutamate. The level of PAF measured in the medium exposed
to glutamate was significantly higher than the level in the medium un
exposed to glutamate (P < 0.05). Our results suggest an important role
of PAF in glutamate neurotoxicity. (C) 1997 Elsevier Science B.V.